We are live on ! Find out more
BSTG

Biostage, Inc. Common Stock
BSTG

Delisted

BSTG was delisted on the 5th of October, 2017.

Back to rankings

24 hedge funds and large institutions have $961K invested in Biostage, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,100% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 1

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

11% less funds holding

Funds holding: 27 → 24 (-3)

38% less capital invested

Capital invested by funds: $1.55M → $961K (-$591K)

Holders
24
Holders Change
-3
Holders Change %
-11.11%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
12
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$334K
2
Renaissance Technologies
Renaissance Technologies
New York
+$202K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$193K
4
Citadel Advisors
Citadel Advisors
Florida
+$24.9K
5
GAG
GM Advisory Group
New York
+$8.22K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$43K
2
TSS
Two Sigma Securities
New York
-$20K
3
EARNEST Partners
EARNEST Partners
Georgia
-$1K
4
Goldman Sachs
Goldman Sachs
New York
-$55
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$273K +$193K +352,784 +90%
Renaissance Technologies
2
Renaissance Technologies
New York
$227K +$202K +369,300 +147%
BlackRock
3
BlackRock
New York
$224K +$334K +610,141 New
WIC
4
Woodmont Investment Counsel
Tennessee
$53K – – –
State of New Jersey Common Pension Fund D
5
State of New Jersey Common Pension Fund D
New Jersey
$39K – – –
California Public Employees Retirement System
6
California Public Employees Retirement System
California
$24K – – –
Citadel Advisors
7
Citadel Advisors
Florida
$17K +$24.9K +45,460 New
UBS Group
8
UBS Group
Switzerland
$16K +$3.62K +6,608 +18%
PAM
9
Panagora Asset Management
Massachusetts
$11K – – –
Bank of New York Mellon
10
Bank of New York Mellon
New York
$11K +$8.16K +14,904 +100%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$10K +$108 +198 +0.7%
Northern Trust
12
Northern Trust
Illinois
$10K +$3.62K +6,611 +35%
VKH
13
Virtu KCG Holdings
New York
$9K +$4.61K +8,414 +49%
Wells Fargo
14
Wells Fargo
California
$9K +$7.11K +12,987 +124%
GAG
15
GM Advisory Group
New York
$6K +$8.22K +15,025 New
Goldman Sachs
16
Goldman Sachs
New York
$5K -$55 -101 -0.8%
Commonwealth Equity Services
17
Commonwealth Equity Services
Massachusetts
$5K +$14 +25 +0.2%
Morgan Stanley
18
Morgan Stanley
New York
$5K +$4.23K +7,726 +131%
BII
19
Bainco International Investors
Massachusetts
$4K +$6.68K +12,200 New
LTFS
20
Ladenburg Thalmann Financial Services
Florida
$2K +$3.56K +6,500 +8,667%
TRCT
21
Tower Research Capital (TRC)
New York
$1K +$1.65K +3,013 +467%
Susquehanna International Group
22
Susquehanna International Group
Pennsylvania
– -$43K -47,879 Closed
TSS
23
Two Sigma Securities
New York
– -$20K -22,997 Closed
EARNEST Partners
24
EARNEST Partners
Georgia
– -$1K -650 Closed

BSTG Hedge Fund Activity: Q1 2017 in Review

24 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Biostage, Inc. Common Stock (BSTG) for Q1 2017, worth a combined $961K — down 38% from $1.55M a quarter earlier.

Fund positioning in BSTG was balanced in Q1 2017: 4 funds opened new positions, 4 closed out, 12 added to existing stakes and 1 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $334K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $43K sold.

  • 24 institutional investors held Biostage, Inc. Common Stock (BSTG) as of Q1 2017, down from 27 in Q4 2016.
  • Funds reported $961K of Biostage, Inc. Common Stock stock for Q1 2017, down 38% quarter-over-quarter.
  • 4 funds opened new Biostage, Inc. Common Stock positions in Q1 2017 and 4 closed out, a net change of 0 holders.
  • The largest Biostage, Inc. Common Stock buyer in Q1 2017 was BlackRock, an estimated $334K added.
  • The largest Biostage, Inc. Common Stock seller in Q1 2017 was Susquehanna International Group, an estimated $43K sold.

Based on aggregated 13F filings for Q1 2017.